93 %Laboratory testing has been conducted on 93% of the suspected mpox cases in Cameroon, with a positivity rate of 10.7%.
CamerounmpoxAfrica CDCdocument of 147 observations
Explore evidence
Gold tier: mechanically validated evidence, with its primary source.
7 evidence items · page 1 / 1
118 genomes118 MPXV genomes were sequenced from cases in Nigeria and Cameroon between 2018 and 2023.
Cameroun · Nigeriampoxobserved 2018 to 2023published 2025Natureeurope_pmcdocument of 5 observations
33.3 %As of 29 September 2024, Cameroon has reported a total of 89 suspected mpox cases, with 6 confirmed cases and 2 deaths, resulting in a case fatality rate of 33.3%.
Camerounmpoxobserved 29 September 2024Africa CDCdocument of 147 observations
5.7 %In Cameroon, the case fatality ratio for mpox was 5.7%.
CamerounmpoxAfrica CDCdocument of 22 observations
Cameroon reported both Clade I and Clade II mpox cases.
CamerounClade I · Clade II · mpoxAfrica CDCdocument of 11 observations
6 confirmed_casesCameroon reported 6 confirmed mpox cases and 2 deaths among confirmed cases in 2024.
Camerounmpoxobserved 2024Africa CDCdocument of 74 observations
Cameroon reported mpox cases belonging to both Clade I and Clade II.
CamerounClade I · Clade II · mpoxAfrica CDCdocument of 11 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.